Key result
A survey of 41 European centres showed adoption of ESC guidelines for AF and ACS, but highlighted uncertainty regarding optimal antithrombotic therapy composition and duration.
Population
41 centres in Europe managing patients with non-valvular atrial fibrillation presenting with acute coronary…
Design
Cross-sectional
Authors
Loading...
Highlights current European practices amid limited evidence for AF with ACS; leaves open need for dedicated trials.
Cross-Sectional (n=41)
Yes
This European survey highlights that while ESC guidelines for AF and ACS are generally adopted, significant uncertainty remains regarding optimal combination antithrombotic therapy.
Potpara et al. (2014) conducted a cross-sectional in Non-valvular atrial fibrillation with acute coronary syndrome (n=41). Management practices was evaluated on Current practice and guideline adoption. A survey of 41 European centres showed adoption of ESC guidelines for AF and ACS, but highlighted uncertainty regarding optimal antithrombotic therapy composition and duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: